This inventor holds 4 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Warner-Lambert Company, Alnylam Pharmaceuticals, Inc.. Active years: 2010-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ann Arbor, MI (US) (2010 - 2013)
- North Wales, PA (US) (2014 - 2015)
Company Filing History:
Years Active: 2010-2015
Title: Kevin Matthew Schlosser: Innovator in Polymer Delivery Systems
Introduction
Kevin Matthew Schlosser is a notable inventor based in Ann Arbor, MI (US). He has made significant contributions to the field of polymer science, particularly in the development of innovative delivery systems for therapeutic applications. With a total of four patents to his name, Schlosser's work has the potential to impact various medical treatments.
Latest Patents
Among his latest patents is the invention of poly(amide) polymers for the delivery of oligonucleotides. This invention provides poly(amide) polymers, polyconjugates, compositions, and methods for the effective delivery of oligonucleotides for therapeutic purposes. Another significant patent is for 4-phenylamino-quinazolin-6-yl-amides, which presents quinazoline compounds of a specific formula, showcasing his innovative approach to chemical compounds.
Career Highlights
Throughout his career, Schlosser has worked with prominent companies such as Warner-Lambert Company and Alnylam Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.
Collaborations
Schlosser has collaborated with notable individuals in his field, including Stephen Alan Fakhoury and Helen Tsenwhei Lee. These collaborations have further enhanced his research and development efforts, leading to advancements in polymer technology.
Conclusion
Kevin Matthew Schlosser is a distinguished inventor whose work in polymer delivery systems is paving the way for new therapeutic solutions. His patents and collaborations reflect his commitment to innovation in the field of science and medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile